{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:24:58Z","timestamp":1787005498897,"version":"build-2736575974"},"reference-count":19,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2000,6,1]],"date-time":"2000-06-01T00:00:00Z","timestamp":959817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2000,6]]},"DOI":"10.1067\/mai.2000.105525","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T00:22:26Z","timestamp":1027556546000},"page":"1101-1107","source":"Crossref","is-referenced-by-count":27,"special_numbering":"P1","title":["Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis"],"prefix":"10.1067","volume":"105","author":[{"given":"Paul H.","family":"Ratner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet C.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George C.","family":"Georges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1067\/mai.2000.105525_bib1","first-page":"32","article-title":"How to determine the cost-effectiveness of available allergic rhinitis treatments","volume":"10","author":"Blaiss","year":"1998","journal-title":"Drug Benefit Trends"},{"key":"10.1067\/mai.2000.105525_bib2","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/0091-6749(87)90286-7","article-title":"The prevalence of allergic skin test reactivity to eight common aeroallergens in the US population: results from the second National Health and Nutrition Examination Survey","volume":"80","author":"Gergen","year":"1987","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mai.2000.105525_bib3","first-page":"285","article-title":"The costs of allergic rhinitis","volume":"2","author":"Ross","year":"1996","journal-title":"Am J Man Care"},{"key":"10.1067\/mai.2000.105525_bib4","first-page":"11","article-title":"Improving the value of care for allergic rhinitis","volume":"8","author":"Stempel","year":"1996","journal-title":"Drug Benefit Trends"},{"key":"10.1067\/mai.2000.105525_bib5","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2165\/00044011-199816060-00001","article-title":"Efficacy and tolerability comparison of ebastine 10 and 20mg with loratadine 10mg: a double-blind, randomised study in patients with perennial allergic rhinitis","volume":"16","author":"Davies","year":"1998","journal-title":"Clin Drug Invest"},{"key":"10.1067\/mai.2000.105525_bib6","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1034\/j.1398-9995.1999.00984.x","article-title":"A twelve-week, placebo-controlled study of the efficacy and safety of ebastine, 10mg and 20mg once-daily, in the treatment of perennial allergic rhinitis","volume":"54","author":"Bousquet","year":"1999","journal-title":"Allergy"},{"key":"10.1067\/mai.2000.105525_bib7","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/BF03259166","article-title":"Efficacy and tolerability of ebastine at two dose levels in the treatment of seasonal allergic rhinitis","volume":"1","author":"De Molina","year":"1989","journal-title":"Drug Invest"},{"issue":"1 Suppl","key":"10.1067\/mai.2000.105525_bib8","doi-asserted-by":"crossref","first-page":"20","DOI":"10.2165\/00003495-199600521-00006","article-title":"Clinical studies of the efficacy and tolerability of ebastine 10 or 20 mg once daily in the treatment of seasonal allergic rhinitis in the US","volume":"52","author":"Storms","year":"1996","journal-title":"Drugs"},{"key":"10.1067\/mai.2000.105525_bib9","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S1081-1206(10)63269-3","article-title":"Comparison of ebastine to cetirizine in seasonal allergic rhinitis in adults","volume":"76","author":"Gehanno","year":"1996","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"26 Suppl","key":"10.1067\/mai.2000.105525_bib10","first-page":"199","article-title":"A double-blind placebo controlled study of the efficacy and tolerability of ebastine and loratadine in seasonal allergic rhinitis patients","volume":"50","author":"Luria","year":"1995","journal-title":"Allergy"},{"key":"10.1067\/mai.2000.105525_bib11","series-title":"Physicians\u2019 desk reference","first-page":"2825","article-title":"Claritin brand of loratadine tablets","year":"1999"},{"key":"10.1067\/mai.2000.105525_bib12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0091-6749(88)90220-5","article-title":"Circadian and circannual rhythms of allergic rhinitis: an epidemiologic study involving chronobiologic methods","volume":"81","author":"Reinberg","year":"1988","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mai.2000.105525_bib13","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/S0091-6749(95)70212-1","article-title":"Twenty-four hour pattern in symptom intensity of viral and allergic rhinitis: treatment implications","volume":"95","author":"Smolensky","year":"1995","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mai.2000.105525_bib14","series-title":"Physician\u2019s desk reference","first-page":"1705","article-title":"Semprex-D capsules (acrivastine and pseudoephedrine HCl)","year":"1999"},{"key":"10.1067\/mai.2000.105525_bib15","first-page":"257","article-title":"Double-blind comparison of cetirizine and placebo in the treatment of seasonal rhinitis","volume":"66","author":"Falliers","year":"1991","journal-title":"Ann Allergy"},{"key":"10.1067\/mai.2000.105525_bib16","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2165\/00003495-199651020-00006","article-title":"Ebastine: a review of its pharmacological properties and clinical efficacy in the treatment of allergic disorders","volume":"51","author":"Wiseman","year":"1996","journal-title":"Drugs"},{"key":"10.1067\/mai.2000.105525_bib17","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2125.1988.tb05289.x","article-title":"Ebastine: the effect of a new antihistamine on psychomotor performance and autonomic responses in healthy subjects","volume":"26","author":"Vincent","year":"1988","journal-title":"Br J Clin Pharmacol"},{"key":"10.1067\/mai.2000.105525_bib18","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/0002-9149(91)90541-R","article-title":"Variability of the QT measurement in healthy men, with implications for selection of an abnormal QT value to predict drug toxicity and proarrhythmia","volume":"67","author":"Morganroth","year":"1991","journal-title":"Am J Cardiol"},{"key":"10.1067\/mai.2000.105525_bib19","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0735-1097(95)00426-2","article-title":"Diurnal pattern of QTc interval: how long is prolonged? Possible relation to circadian triggers of cardiovascular events","volume":"27","author":"Molnar","year":"1996","journal-title":"J Am Coll Cardiol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674900700443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674900700443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T07:27:28Z","timestamp":1557386848000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674900700443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,6]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2000,6]]}},"alternative-id":["S0091674900700443"],"URL":"https:\/\/doi.org\/10.1067\/mai.2000.105525","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2000,6]]}}}